Evidence map›Paper›PMID 40563863›Full record

ReviewBiology2025

Glycosylation and Acylation: Important Regulators of Immune Cell Fate Decisions.

Han Wang, Yiying Zhang, Xu Luo, Xinxin Zheng, Guangdong Bai, Junhui Liu

Abstract readReview
In one paragraph

Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Post-Translational Regulation of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Post-translational modifications in CD8Frontiers in immunology · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Han WangCollege of Animal Science and Technology, Southwest University, Chongqing 400715, China.
Yiying ZhangCollege of Animal Science and Technology, Southwest University, Chongqing 400715, China.
Xu LuoCollege of Animal Science and Technology, Southwest University, Chongqing 400715, China.
Xinxin ZhengCollege of Animal Science and Technology, Southwest University, Chongqing 400715, China.
Guangdong BaiCollege of Animal Science and Technology, Southwest University, Chongqing 400715, China.ORCID 0009-0002-5820-1633
Junhui LiuCollege of Animal Science and Technology, Southwest University, Chongqing 400715, China.

Funding

Fundamental Research Funds for the Central Universities SWU-KR24022National College Students' Innovation and Entrepreneurship Training Program Project of South-west University 202410635078
6 · The paper itself

Abstract

Dissecting the determinants of immune cell fate is a central challenge in immunology and is important for understanding cell differentiation, disease diagnosis, and therapy. Post-translational modifications (PTMs) of proteins are chemical modifications of amino acids involving the addition or removal of specific groups. As molecular gatekeepers of immune cell fate, PTMs affect immune function mainly through the regulation of important life processes such as immune cell growth, proliferation, differentiation, activation, and apoptosis. Among PTMs, glycosylation and acylation have emerged as critical regulatory mechanisms governing immune homeostasis. Through precise structural alterations of immune-related proteins and receptors, glycosylation shapes antigen recognition, cytokine signaling, and intercellular communication, while acylation regulates signal transduction and epigenetic modifications in both innate and adaptive immunity. These modifications are involved in the regulation of a wide range of biological processes and are intricately associated with the pathogenesis of many diseases, especially immune diseases. Therefore, this paper reviews the functions and mechanisms of glycosylation and acylation in regulating innate and acquired immunity, to provide new insights into the role of PTMs in disease pathogenesis and potential targeted therapies.

Indexed as

acetylationcrotonylationglycosylationimmune cell fateimmune diseasessuccinylation

Identifiers

PMID40563863
PMCPMC12189780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.